Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
386,127,219
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
36,719,372
-
Shares change
-
+692,039
-
Total reported value, excl. options
-
$217,359,750
-
Value change
-
+$4,379,642
-
Put/Call ratio
-
106%
-
Number of buys
-
45
-
Number of sells
-
-29
-
Price
-
$5.89
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q4 2017
94 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share as of Q4 2017.
STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36,719,372 shares
of 386,127,219 outstanding shares and own 9.5% of the company stock.
Largest 10 shareholders include LEVIN CAPITAL STRATEGIES, L.P. (9,167,070 shares), PRIMECAP MANAGEMENT CO/CA/ (5,775,143 shares), Neuberger Berman Group LLC (4,745,356 shares), Russell Investments Group, Ltd. (3,831,239 shares), BlackRock Inc. (2,184,882 shares), ORBIMED ADVISORS LLC (1,583,700 shares), Vanguard Group Inc (1,324,789 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1,184,133 shares), RENAISSANCE TECHNOLOGIES LLC (805,300 shares), and STATE STREET CORP (550,488 shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.